Towards Definitive Management of Allergic Rhinitis
Best use of new and established therapies
Allergic rhinitis (AR) is an inflammatory disease of the nasal mucosa impacting almost 25% of Canadians and up to 38.5% of South Africans. The standard of care for AR includes a treatment plan that takes into account patient preferences, the severity of the disease, and most essentially involves a shared decision-making process between patient and provider. This is a shortened version of the original open access article.
Modern Medicine – Issue 3 2021
